Life Sciences Pulse
Life Sciences Pulse
Targeting growth equity investments in highly innovative life sciences businesses
The strategy seeks to invest in companies operating in specific areas of innovation, including therapeutics, diagnostics, and life sciences tools. By leveraging Sands Capital’s global research platform to source, assess, and structure investment opportunities, Sands Capital partners with pioneers in the expanding class of innovative life sciences businesses.
As of October 1, 2021, the firm was redefined to be the combination of Sands Capital Management, LLC and Sands Capital Ventures, LLC. The two investment advisers are combined to be one firm for GIPS® purposes and are doing business as Sands Capital. Sands Capital operates as a distinct business organization, retains discretion over the assets between the two registered investment advisers, and has autonomy over the total investment decision making process.
Our Investment Focus
In addition to the six criteria that guide all investment decisions at Sands Capital, Life Sciences Pulse invests in businesses that fit the following criteria:
Sector
Innovative life sciences business who are leaders in therapeutics, diagnostics, and life sciences tools
Stage
Businesses with meaningful clinical data, proof of concept data, and/or promising business models
Geography
Targeting major innovation hubs around the globe
Concentration
$15 million – $30 million target investment size per company
Portfolio Businesses
Strategy Team
A bold mission requires a strong team. We sought out individuals who share our passion and have assembled a deep and diverse bench of investment, legal, operational, and financial personnel to execute on our mission.
